Brazil is rapidly emerging as a world leader in innovation and development in the pharmaceutical, medical device and food industries. Stakeholders ranging from multinational companies to small startups are staking a foothold in the region. The US Food and Drug Administration (FDA) and the Brazilian National Health Surveillance Agency (ANVISA) are working together to safeguard the integrity of the products being exchanged between the two countries and by extension across the globe.
Understanding the current legal, regulatory and economic environment for the development and sale of pharmaceuticals, medical devices and food in both countries is imperative for anyone doing business, or working with clients who are doing business, between the two countries. Join the Food and Drug Law Institute (FDLI) for a two-day conference where government officials and internationally renowned experts will discuss pharmaceutical, medical device, and food law, regulation, and policy in the US and Brazil. The conference will focus on business opportunities and policy challenges of producing safe products and promoting public health.
- Food and Drug Attorneys
- Government Officials
- Food and Drug Industry Consultants
- Venture Capitalists and Investment Brokers
Representatives of multinational pharmaceutical, medical device and food companies doing business or planning to do business in Brazil, and representatives of Brazilian companies who wish to partner with these multinational companies:
- Regulatory Affairs Professionals
- Government Affairs Professionals
- Safety Officers
- Compliance Officers
- Legal Counsel
- Business Development Professionals
- Global Strategy Professionals
- Corporate Planning Professionals
Uploaded by CBSNewsOnline on Dec 12, 2010
As the U.S. and most of the world's countries limp along after the crippling recession, Brazil is off and running with jobs, industry, and resources. Steve Kroft reports.